The Middleby
MIDD
105.24
-0.68
-0.64%
The Middleby
US · MIDD
#2157 by market cap
Listed 1970
105.24
-0.68
-0.64%
Live - 5344 symbols - heartbeat 362s ago
· 2026-10-08 07:21
Pre-market
103.01
-2.12%
After-hours
105.24
0.00%
- Market cap
- 4.76B
- P/E (TTM)i
- -11.75
- P/Bi
- 2.15
- EPSi
- -5.38
- Div yieldi
- 0.00%
- 52W posi
- 27%
Reader sentiment
Are you bullish or bearish on MIDD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.84, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.62% YoY
Margins
- Gross margin
- 39.11%
- Operating margin
- 18.39%
- Net margin
- -8.68%
Key ratios & quality
- Enterprise valuei
- 6.73B
- Altman Z-Scorei
- 2.84
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.72B | 2.96B | 2.51B | 3.25B | 4.03B | 3.24B | 3.15B | 3.20B |
| Gross profit | 1.00B | 1.10B | 882.05M | 1.19B | 1.45B | 1.28B | 1.25B | 1.25B |
| Selling & admin expenses | 538.84M | 593.81M | 531.90M | 667.98M | 797.23M | 624.93M | 590.12M | 663.16M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 465.30M | 509.68M | 350.15M | 526.88M | 649.32M | 659.15M | 661.70M | 588.76M |
| Pretax profit | 423.51M | 462.62M | 268.06M | 619.50M | 564.42M | 536.08M | 566.10M | 482.28M |
| Tax | 106.36M | 110.38M | 60.76M | 131.01M | 127.85M | 123.08M | 145.12M | 115.01M |
| Net profit | 317.15M | 352.24M | 207.29M | 488.49M | 436.57M | 400.88M | 428.43M | -277.73M |
| Basic EPS | 6 | 6 | 4 | 9 | 8 | 7 | 8 | -5 |
| Diluted EPS | 5.70 | 6.33 | 3.76 | 8.62 | 7.95 | 7.41 | 7.90 | -5.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 730.62M | 796.80M | 982.13M | 334.59M | 839.91M | 875.55M |
| Gross profit | 292.58M | 316.10M | 361.31M | 173.39M | 323.19M | 335.08M |
| Selling & admin expenses | 161.81M | 167.60M | 203.62M | 43.32M | 188.30M | 186.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 130.77M | 148.50M | 157.69M | 130.06M | 134.89M | 148.48M |
| Pretax profit | 111.26M | 127.03M | -578.95M | 806.78M | 112.92M | 126.38M |
| Tax | 26.19M | 25.37M | -65.97M | 124.84M | 27.64M | 43.28M |
| Net profit | 92.35M | 105.96M | -512.98M | 36.94M | -50.07M | 54.81M |
| Basic EPS | 2 | 2 | -10 | 1 | -1 | 1 |
| Diluted EPS | 1.69 | 1.99 | -10.15 | 0.74 | -1.06 | 1.21 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.06B | 1.21B | 1.27B | 1.71B | 2.01B | 1.97B | 2.33B | 2.74B |
| Cash & ST investments | 71.70M | 94.50M | 268.10M | 180.36M | 162.00M | 247.50M | 638.77M | 222.24M |
| Inventory | 521.81M | 585.70M | 540.20M | 837.42M | 1.08B | 935.87M | 655.94M | 692.59M |
| Total assets | 4.55B | 5.00B | 5.20B | 6.38B | 6.87B | 6.91B | 7.28B | 6.32B |
| Total current liabilities | 558.95M | 593.14M | 700.26M | 914.89M | 988.28M | 851.09M | 829.32M | 1.07B |
| Short-term debt | 3.21M | 24.72M | 45.44M | 50.05M | 70.83M | 71.24M | 61.78M | 63.94M |
| Long-term debt | 1.89B | 1.87B | 1.71B | 2.39B | 2.68B | 2.38B | 2.35B | 2.13B |
| Total liabilities | 2,884,578,000.00 | 3,055,329,000.00 | 3,225,825,000.00 | 3,889,322,000.00 | 4,077,119,000.00 | 3,656,803,000.00 | 3,644,720,000.00 | 3,538,937,000.00 |
| Total equity | 1.67B | 1.95B | 1.98B | 2.49B | 2.80B | 3.25B | 3.64B | 2.78B |
| Retained earnings | 2.01B | 2.36B | 2.57B | 3.06B | 3.50B | 3.90B | 4.33B | 4.05B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.41B | 2.26B | 1.97B | 2.74B | 1.65B | 1.64B |
| Cash & ST investments | 745.14M | 511.50M | 175.13M | 222.24M | 177.07M | 159.18M |
| Inventory | 877.73M | 888.67M | 919.55M | 692.59M | 728.39M | 737.63M |
| Total assets | 7.40B | 7.34B | 6.35B | 6.32B | 5.42B | 5.36B |
| Total current liabilities | 885.82M | 880.78M | 951.56M | 1.07B | 838.79M | 827.29M |
| Short-term debt | 71.29M | 71.32M | 70.34M | 63.94M | 65.29M | 64.93M |
| Long-term debt | 2.34B | 2.33B | 2.03B | 2.13B | 1.83B | 1.94B |
| Total liabilities | 3,671,460,000.00 | 3,713,328,000.00 | 3,416,875,000.00 | 3,538,937,000.00 | 3,047,056,000.00 | 3,150,699,000.00 |
| Total equity | 3.73B | 3.62B | 2.94B | 2.78B | 2.37B | 2.21B |
| Retained earnings | 4.42B | 4.53B | 4.01B | 4.05B | 4.00B | 4.06B |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 368.91M | 377.43M | 524.79M | 423.40M | 332.55M | 628.79M | 686.82M | 630.20M |
| Depreciation & amortization | 97.24M | 103.43M | 110.53M | 125.24M | 138.06M | 109.92M | 104.11M | 105.31M |
| Free cash flow | 327.48M | 330.82M | 482.88M | 371.85M | 263.03M | 567.92M | 650.05M | 558.35M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -6.14M | -85.87M | -29.27M | -264.78M | -74.57M | -34.66M | -723.61M |
| Ending cash balance | 71.70M | 94.50M | 268.10M | 180.36M | 162.00M | 247.50M | 689.53M | 244.45M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 141.13M | 122.00M | 176.34M | 190.72M | 65.61M | 97.72M |
| Depreciation & amortization | 26.35M | 26.06M | 44.75M | 8.14M | 25.47M | 25.77M |
| Free cash flow | 113.56M | 107.40M | 142.49M | 194.91M | 57.67M | 87.03M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -42.78M | -322.91M | -148.61M | -209.31M | -374.78M | -207.10M |
| Ending cash balance | 745.14M | 511.50M | 175.13M | 244.45M | 177.79M | 160.06M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.96 | 19.50 | 10.57 | 21.85 | 16.50 | 13.26 | 12.44 | -8.66 |
| ROA %i | 8.04 | 7.38 | 4.06 | 8.43 | 6.59 | 5.82 | 6.04 | -4.08 |
| ROIC %i | 12.14 | 11.22 | 7.08 | 12.32 | 9.65 | 8.78 | 8.45 | -3.74 |
| 5-year avg ROE %i | 21.12 | 20.83 | 19.42 | 19.12 | 17.88 | 16.34 | 14.92 | 11.08 |
| EBIT margin %i | 17.71 | 18.42 | 13.79 | 20.82 | 16.20 | 15.85 | 17.28 | 18.00 |
| FCF / sales %i | 12.03 | 11.18 | 19.21 | 11.44 | 6.52 | 13.42 | 16.45 | 17.44 |
| Current ratioi | 1.90 | 2.04 | 1.81 | 1.87 | 2.03 | 2.31 | 2.81 | 2.57 |
| Quick ratioi | 0.84 | 0.91 | 0.90 | 0.83 | 0.80 | 1.05 | 1.41 | 0.74 |
| Debt / assetsi | 41.59 | 37.88 | 33.68 | 38.18 | 39.97 | 35.50 | 33.13 | 34.72 |
| LT debt / equityi | 113.43 | 96.07 | 86.34 | 95.70 | 95.67 | 73.24 | 64.62 | 76.67 |
| Interest coveragei | 8.21 | 6.60 | 4.41 | 11.84 | 7.34 | 5.32 | 7.26 | 6.14 |
| Revenue CAGR (3Y) %i | 14.23 | 9.28 | 2.47 | 6.08 | 10.87 | 8.86 | -1.04 | -7.41 |
| Net income CAGR (3Y) %i | 18.29 | 7.41 | -11.41 | 15.49 | 7.42 | 24.59 | -4.28 | -- |
| FCF CAGR (3Y) %i | 12.95 | 7.10 | 24.54 | 4.33 | -7.36 | 5.56 | 20.46 | 28.52 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 12.33 | 12.06 | -6.20 | -8.66 | -13.76 | -16.16 |
| ROA %i | 6.06 | 5.92 | -2.99 | -4.08 | -6.55 | -7.42 |
| ROIC %i | 8.36 | 8.17 | -2.47 | -3.74 | -6.60 | -7.71 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.34 | 16.71 | -2.27 | 18.00 | 17.65 | 17.39 |
| FCF / sales %i | 16.00 | 15.08 | 15.21 | 17.44 | 15.18 | 14.22 |
| Current ratioi | 2.72 | 2.57 | 2.07 | 2.57 | 1.96 | 1.99 |
| Quick ratioi | 1.57 | 1.34 | 0.89 | 0.74 | 0.94 | 0.92 |
| Debt / assetsi | 32.60 | 32.76 | 32.97 | 34.72 | 34.95 | 37.32 |
| LT debt / equityi | 62.77 | 64.37 | 68.93 | 76.67 | 77.05 | 87.58 |
| Interest coveragei | 7.93 | 8.06 | -1.06 | 6.14 | 5.82 | 5.55 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Commercial Foodservice is the largest reported line at 72.02% of revenue, across 2 reported segments.
- The next-largest line, Food processing, is a distant second at 27.98% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Commercial Foodservice72.02%
Food processing27.98%
Quote time 2026-10-08 07:21:47 · For reference only, not investment advice and not tailored to your situation.